Original Research
Accepted on 06 Feb 2026
Stereotactic body radiotherapy plus lenvatinib and sintilimab with and without transarterial embolization for advanced hepatocellular carcinoma with portal vein tumor thrombus: A dual-center, propensity score-matched retrospective analysis
in Cancer Immunity and Immunotherapy